ZACKS
Search documents
BKV (BKV) Earnings Expected to Grow: Should You Buy?
ZACKS· 2026-02-18 16:00
Wall Street expects a year-over-year increase in earnings on higher revenues when BKV (BKV) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 25. On the ...
Bank of Montreal (BMO) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2026-02-18 16:00
Bank of Montreal (BMO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Febru ...
Earnings Preview: APA (APA) Q4 Earnings Expected to Decline
ZACKS· 2026-02-18 16:00
APA (APA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 25, might help the stock move higher if these key numbers are better than expectations. ...
Dine Brands (DIN) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2026-02-18 16:00
The market expects Dine Brands (DIN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 25, might help the stock move higher if these key numbers are be ...
Heico Corporation (HEI) Earnings Expected to Grow: What to Know Ahead of Q1 Release
ZACKS· 2026-02-18 16:00
The market expects Heico Corporation (HEI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if ...
SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy
ZACKS· 2026-02-18 15:55
Core Insights - STRATA Skin Sciences, Inc. (SSKN) has highlighted findings from a meta-analysis that supports the clinical efficacy of its 308 nm excimer laser technology for treating plaque psoriasis [1][12] - The meta-analysis, published in a peer-reviewed journal, indicates significant improvements in disease severity scores following targeted treatment protocols [1][10] Company Performance - Following the announcement of the meta-analysis, SSKN shares fell more than 8%, and the stock has decreased by 82.3% over the last six months, compared to a 37% decline in the industry [3][8] - The current market capitalization of SSKN is $2 million [6] Clinical Validation and Market Position - The findings from the meta-analysis provide independent validation of SSKN's excimer laser technology, which may enhance physician adoption and patient confidence [4][12] - The pooled data from the analysis showed PASI reductions of 56%-85% within 10-14 treatments, confirming the effectiveness of MED-guided dosing strategies [8][10] - The publication emphasizes the importance of MED-guided calibration for targeted UVB delivery, which can improve treatment outcomes while minimizing damage to healthy skin [11][12] Industry Outlook - The global psoriasis treatment market was valued at $34.14 billion in 2025 and is projected to grow to approximately $73.04 billion by 2035, with a CAGR of 7.9% [13] - The growth in the market is driven by increasing prevalence, better diagnosis, and demand for effective therapies, alongside innovations in biologics and device-based treatments [14]
MCO Q4 Earnings Beat on Rising Analytics Demand & High Issuance Volume
ZACKS· 2026-02-18 15:55
Core Insights - Moody's reported fourth-quarter 2025 adjusted earnings of $3.64 per share, exceeding the Zacks Consensus Estimate of $3.46, with a year-over-year growth of 39% [1][8] - The company's revenues improved significantly, driven by strong demand for analytics and robust performance in the Moody's Investors Service segment [1][5] - Moody's liquidity position remained strong, although a modest increase in operating expenses presented a challenge [1] Financial Performance - Net income attributable to Moody's was $610 million or $3.41 per share, up from $395 million or $2.17 per share in the prior-year quarter [2] - For 2025, adjusted earnings per share reached $14.94, a 20% increase, surpassing the consensus estimate of $14.78 [2] - Quarterly revenues were $1.89 billion, exceeding the Zacks Consensus Estimate of $1.88 billion, with a year-over-year increase of 13% [3] - Total expenses rose to $1.12 billion, an increase of almost 1% year over year [3] Segment Performance - Moody's Investors Service revenues increased by 17% year over year to $946 million, driven by strong performance across various finance categories [5] - Moody's Analytics revenues rose by 9% year over year to $943 million, supported by growth in Decision Solutions, Research and Insights, and Data & Information [5] Balance Sheet and Share Repurchase - As of December 31, 2025, Moody's had total cash and short-term investments of $2.45 billion, down from $2.97 billion a year earlier [6] - The company had $7 billion in outstanding debt and $1.25 billion in additional borrowing capacity [6] - In the quarter, Moody's repurchased 0.9 million shares at an average price of $485.55, with $4 billion of share repurchase authorization still available [7][9] 2026 Guidance - Moody's expects adjusted earnings in the range of $16.40-$17.00 per share and GAAP earnings between $15.00-$15.60 per share for 2026 [10] - Revenue growth is projected to be in the high-single-digit percent range, with operating expenses expected to increase in the mid-single-digit range [10]
APLD vs. VRT: Which Data Center Infrastructure Stock is a Better Buy?
ZACKS· 2026-02-18 15:55
Core Insights - Applied Digital (APLD) and Vertiv Holdings (VRT) are positioned in the data center infrastructure market, focusing on AI-driven facilities and critical power systems respectively [1][6] - The global Data Center Infrastructure Management market is expected to grow from $4.29 billion in 2026 to $9.99 billion by 2031, with a CAGR of 18.43% [2] Applied Digital (APLD) - APLD is strategically positioned to benefit from the growth of AI-focused data centers, emphasizing energy-efficient design and scalable power architecture [3] - The company has contracted 600 megawatts across Polaris Forge 1 and 2, representing approximately $16 billion in potential lease revenues [4] - APLD's fiscal 2026 loss is estimated at 36 cents per share, indicating a year-over-year improvement of 55% [5] Vertiv Holdings (VRT) - VRT provides essential power and thermal management solutions for data centers, serving customers in 130 countries [6] - The company is co-developing an 800-volt DC power architecture with NVIDIA, ensuring its solutions remain relevant as power requirements increase [7] - VRT has a backlog of $15 billion and a book-to-bill ratio of approximately 2.9x, indicating strong revenue visibility [9] Stock Performance and Valuation - Over the past six months, VRT shares have increased by 88.7%, while APLD shares have surged by 118.7% [11] - VRT is trading at a forward price-to-sales ratio of 6.95x, significantly lower than APLD's 19.95x, suggesting a more attractive valuation for VRT [14] - VRT is currently rated as a Zacks Rank 1 (Strong Buy), while APLD holds a Zacks Rank 3 (Hold) [19]
EQT Q4 Earnings Top Estimates on Higher Realized Gas-Equivalent Prices
ZACKS· 2026-02-18 15:55
Financial Performance - EQT Corporation reported fourth-quarter 2025 adjusted earnings from continuing operations of 90 cents per share, exceeding the Zacks Consensus Estimate of 73 cents and up from 67 cents in the prior year [1] - Adjusted operating revenues increased to $2,094 million from $1,821 million in the prior-year quarter, surpassing the Zacks Consensus Estimate of $2,064 million [1] Production and Sales - Sales volume increased to 609 billion cubic feet equivalent (Bcfe) from 605 Bcfe in the year-ago quarter, beating the estimate of 598 Bcfe [3] - Natural gas sales volume was 572 Bcf, up from 566 Bcf in the year-ago quarter, exceeding the estimate of 561 Bcf [3] - Total liquid sales volume decreased to 6,127 thousand barrels (MBbls) from 6,552 MBbls in the prior year, missing the projection of 6,145 MBbls [3] Commodity Prices - The average realized price was $3.44 per thousand cubic feet of natural gas equivalent (Mcfe), up from $3.01 year over year [4] - The average natural gas price, including cash-settled derivatives, was $3.32 per Mcf, an increase from $2.86 [4] - The natural gas sales price was $3.76 per Mcf, higher than $2.97 recorded a year ago [4] - The oil price was $44.98 per barrel compared to $54.75 in the prior year [5] Expenses - Total operating expenses were $1,372 million, up from $843 million in the prior-year quarter [6] - Gathering expenses totaled 10 cents per Mcfe, up from 9 cents year over year [6] - Transmission expenses stood at 40 cents per Mcfe, down from 41 cents recorded a year ago [6] - Lease operating expenses amounted to 11 cents per Mcfe, higher than 9 cents in the corresponding period of 2024 [6] - Selling, general and administrative expenses came in at 18 cents per Mcfe, flat year over year [6] Cash Flow - Adjusted operating cash flow totaled $1.55 billion in the reported quarter, up from $1.23 billion a year ago [7] - Free cash flow amounted to $857 million, an increase from $588 million in the corresponding period of 2024 [7] Capital Expenditure and Balance Sheet - Total capital expenditure was $655 million, higher than $583 million reported a year ago [9] - As of December 31, 2025, the company had cash and cash equivalents of $111 million and net debt worth $7.69 billion [9] Guidance - For the first quarter of 2026, EQT expects total sales volume to be between 560 Bcfe and 610 Bcfe [10] - Total sales volume is forecasted to be in the range of 2,275-2,375 Bcfe for 2026 [10] - Total maintenance capital expenditures are projected to be between $515 million and $590 million, with growth capital expenditures anticipated to be between $120 million and $145 million in the first quarter [10]
Celanese Q4 Earnings Miss Estimates, Revenues Decline Y/Y
ZACKS· 2026-02-18 15:55
Core Insights - Celanese Corporation (CE) reported a fourth-quarter 2025 earnings from continuing operations of 23 cents per share, a significant improvement from a loss of $17.55 in the prior-year quarter. Adjusted earnings were 67 cents per share, down 49.6% from $1.33 a year ago, and missed the Zacks Consensus Estimate of 89 cents [1][9]. Financial Performance - Revenues for the quarter were $2,204 million, a decrease of approximately 7% year over year, missing the Zacks Consensus Estimate of $2,229.9 million. The decline was attributed to reduced volumes and prices, driven by year-end destocking and a competitive environment [2]. - The Engineered Materials unit reported net sales of $1,277 million, up about 0.6% year over year, exceeding the estimate of $1,196.7 million. This segment generated an operating profit of $111 million and an adjusted EBIT of $183 million [3]. - The Acetyl Chain segment saw net sales of $940 million, down roughly 15.3% year over year, missing the estimate of $1,035.1 million. It generated an operating profit of $90 million and an adjusted EBIT of $146 million [4]. - Celanese ended the quarter with cash and cash equivalents of $1,263 million, down approximately 12.3% sequentially. Long-term debt decreased by 2.2% sequentially to $11,394 million. Cash provided by operating activities was $252 million, with free cash flow at $160 million [5]. Future Outlook - The company anticipates volume improvements in the first quarter due to seasonality and ongoing cost reduction initiatives, projecting first-quarter adjusted earnings per share to be between 70 cents and 85 cents [6]. - Management is focused on generating cash flow to accelerate deleveraging, intensifying cost improvements, and driving top-line growth, with a target for 2026 free cash flow set at $650 to $750 million [7]. Market Performance - Celanese's shares have increased by 6.5% over the past year, compared to a 4.4% rise in the industry [8].